Cipla’s Avenue Receives Second CRL For Intravenous Tramadol

As Company Continues To Pursue FDA Approval For The Painkiller

Arm Wrestle
Avenue and FDA lock horns over the regulatory approval of IV tramadol • Source: Alamy

More from Value Added Medicines

More from Products